vs

Side-by-side financial comparison of Arch Capital Group (ACGL) and Quest Diagnostics (DGX). Click either name above to swap in a different company.

Arch Capital Group is the larger business by last-quarter revenue ($4.5B vs $2.9B, roughly 1.6× Quest Diagnostics). Arch Capital Group runs the higher net margin — 23.2% vs 9.7%, a 13.5% gap on every dollar of revenue. On growth, Quest Diagnostics posted the faster year-over-year revenue change (9.2% vs -3.3%). Over the past eight quarters, Quest Diagnostics's revenue compounded faster (9.9% CAGR vs 3.4%).

Arch Capital Group Ltd. is a Bermuda exempted public company which writes insurance, reinsurance and mortgage insurance on a worldwide basis, with a focus on specialty lines, the segment of the insurance industry where the more difficult and unusual risks are written. The company is headquartered in Bermuda and operates globally in 60 offices in North America, Europe, Asia and Australia.

Quest Diagnostics Incorporated is an American clinical laboratory. A Fortune 500 company, Quest operates in the United States, Puerto Rico, Mexico, and Brazil. Quest also maintains collaborative agreements with various hospitals and clinics across the globe.

ACGL vs DGX — Head-to-Head

Bigger by revenue
ACGL
ACGL
1.6× larger
ACGL
$4.5B
$2.9B
DGX
Growing faster (revenue YoY)
DGX
DGX
+12.4% gap
DGX
9.2%
-3.3%
ACGL
Higher net margin
ACGL
ACGL
13.5% more per $
ACGL
23.2%
9.7%
DGX
Faster 2-yr revenue CAGR
DGX
DGX
Annualised
DGX
9.9%
3.4%
ACGL

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
ACGL
ACGL
DGX
DGX
Revenue
$4.5B
$2.9B
Net Profit
$1.0B
$281.0M
Gross Margin
Operating Margin
15.4%
Net Margin
23.2%
9.7%
Revenue YoY
-3.3%
9.2%
Net Profit YoY
82.4%
12.0%
EPS (diluted)
$2.88
$2.24

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ACGL
ACGL
DGX
DGX
Q1 26
$4.5B
$2.9B
Q4 25
$4.9B
$2.8B
Q3 25
$5.1B
$2.8B
Q2 25
$5.2B
$2.8B
Q1 25
$4.7B
$2.7B
Q4 24
$4.5B
$2.6B
Q3 24
$4.7B
$2.5B
Q2 24
$4.2B
$2.4B
Net Profit
ACGL
ACGL
DGX
DGX
Q1 26
$1.0B
$281.0M
Q4 25
$1.2B
$245.0M
Q3 25
$1.4B
$245.0M
Q2 25
$1.2B
$282.0M
Q1 25
$574.0M
$220.0M
Q4 24
$935.0M
$222.0M
Q3 24
$988.0M
$226.0M
Q2 24
$1.3B
$229.0M
Gross Margin
ACGL
ACGL
DGX
DGX
Q1 26
Q4 25
32.4%
Q3 25
33.7%
Q2 25
34.2%
Q1 25
32.5%
Q4 24
32.7%
Q3 24
32.6%
Q2 24
33.5%
Operating Margin
ACGL
ACGL
DGX
DGX
Q1 26
15.4%
Q4 25
13.8%
Q3 25
13.7%
Q2 25
15.9%
Q1 25
13.0%
Q4 24
13.8%
Q3 24
13.3%
Q2 24
14.8%
Net Margin
ACGL
ACGL
DGX
DGX
Q1 26
23.2%
9.7%
Q4 25
25.1%
8.7%
Q3 25
26.4%
8.7%
Q2 25
23.7%
10.2%
Q1 25
12.3%
8.3%
Q4 24
20.6%
8.5%
Q3 24
20.9%
9.1%
Q2 24
30.0%
9.6%
EPS (diluted)
ACGL
ACGL
DGX
DGX
Q1 26
$2.88
$2.24
Q4 25
$3.33
$2.18
Q3 25
$3.56
$2.16
Q2 25
$3.23
$2.47
Q1 25
$1.48
$1.94
Q4 24
$2.41
$1.95
Q3 24
$2.56
$1.99
Q2 24
$3.30
$2.03

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ACGL
ACGL
DGX
DGX
Cash + ST InvestmentsLiquidity on hand
$24.0M
$393.0M
Total DebtLower is stronger
$5.7B
Stockholders' EquityBook value
$24.2B
$7.7B
Total Assets
$81.4B
$16.7B
Debt / EquityLower = less leverage
0.74×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ACGL
ACGL
DGX
DGX
Q1 26
$24.0M
$393.0M
Q4 25
$993.0M
$420.0M
Q3 25
$1.1B
$432.0M
Q2 25
$983.0M
$319.0M
Q1 25
$1.2B
$188.0M
Q4 24
$979.0M
$549.0M
Q3 24
$1.0B
$764.0M
Q2 24
$1.0B
$271.0M
Total Debt
ACGL
ACGL
DGX
DGX
Q1 26
$5.7B
Q4 25
$5.2B
Q3 25
$5.2B
Q2 25
$5.2B
Q1 25
$5.9B
Q4 24
$5.6B
Q3 24
$5.6B
Q2 24
$3.8B
Stockholders' Equity
ACGL
ACGL
DGX
DGX
Q1 26
$24.2B
$7.7B
Q4 25
$24.2B
$7.2B
Q3 25
$23.7B
$7.3B
Q2 25
$23.0B
$7.2B
Q1 25
$21.5B
$6.9B
Q4 24
$20.8B
$6.8B
Q3 24
$22.3B
$6.8B
Q2 24
$20.7B
$6.6B
Total Assets
ACGL
ACGL
DGX
DGX
Q1 26
$81.4B
$16.7B
Q4 25
$79.2B
$16.2B
Q3 25
$79.2B
$16.2B
Q2 25
$78.8B
$16.0B
Q1 25
$75.2B
$15.8B
Q4 24
$70.9B
$16.2B
Q3 24
$73.7B
$16.1B
Q2 24
$65.5B
$13.9B
Debt / Equity
ACGL
ACGL
DGX
DGX
Q1 26
0.74×
Q4 25
0.72×
Q3 25
0.71×
Q2 25
0.72×
Q1 25
0.85×
Q4 24
0.83×
Q3 24
0.83×
Q2 24
0.58×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ACGL
ACGL
DGX
DGX
Operating Cash FlowLast quarter
$1.2B
$278.0M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
3.9%
Cash ConversionOCF / Net Profit
1.13×
0.99×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ACGL
ACGL
DGX
DGX
Q1 26
$1.2B
$278.0M
Q4 25
$1.4B
$465.0M
Q3 25
$2.2B
$563.0M
Q2 25
$1.1B
$544.0M
Q1 25
$1.5B
$314.0M
Q4 24
$1.6B
$464.0M
Q3 24
$2.0B
$356.0M
Q2 24
$1.5B
$360.0M
Free Cash Flow
ACGL
ACGL
DGX
DGX
Q1 26
Q4 25
$1.4B
$307.0M
Q3 25
$2.2B
$419.0M
Q2 25
$1.1B
$436.0M
Q1 25
$1.4B
$197.0M
Q4 24
$1.6B
$341.0M
Q3 24
$2.0B
$250.0M
Q2 24
$1.5B
$268.0M
FCF Margin
ACGL
ACGL
DGX
DGX
Q1 26
Q4 25
28.2%
10.9%
Q3 25
42.6%
14.9%
Q2 25
21.3%
15.8%
Q1 25
31.0%
7.4%
Q4 24
34.3%
13.0%
Q3 24
42.5%
10.0%
Q2 24
35.6%
11.2%
Capex Intensity
ACGL
ACGL
DGX
DGX
Q1 26
3.9%
Q4 25
0.2%
5.6%
Q3 25
0.2%
5.1%
Q2 25
0.2%
3.9%
Q1 25
0.2%
4.4%
Q4 24
0.3%
4.7%
Q3 24
0.3%
4.3%
Q2 24
0.3%
3.8%
Cash Conversion
ACGL
ACGL
DGX
DGX
Q1 26
1.13×
0.99×
Q4 25
1.13×
1.90×
Q3 25
1.62×
2.30×
Q2 25
0.91×
1.93×
Q1 25
2.54×
1.43×
Q4 24
1.68×
2.09×
Q3 24
2.04×
1.58×
Q2 24
1.20×
1.57×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons